INTRODUCTION
Florida is the fourth largest state in the nation, has the nation's fourth largest live birth rate, is home to an estimated million children less than 72 months of age and has over 300,000
Medicaid-eligible children in the same age range. The many subtle demographic and socioeconomic differences in this pediatric population underscore the importance of addressing the preventable condition of childhood lead poisoning. The Centers for Disease Control and For calendar year 1999, 38,091 total tests were performed on an unduplicated count of 35,546 children less than 72 months of age. These reports were submitted by the Department of Health, Bureau of Laboratories (state laboratory) and by reporting private laboratories. The Program does not regularly produce rates because many children are not screened and private laboratories often submit data that exclude results less than ten micrograms per deciliter. 1. Name and date of birth of the patient from whom the specimen was taken; 2. Name, address, and telephone number of the processing laboratory; and 3. Diagnostic test performed, specimen type and result In addition to the above, they must supply either of the following: a. Address, telephone number, race, sex, ethnicity and social security number (pending) of the patient, or, if these are not available then b. Name, address, and telephone number of the submitting physician or health care provider
In addition to these minimum mandatory requirements outlined in the Administrative Code, the Surveillance Program also requests:
1. An indication if the individual is receiving Medicaid; 2. That all blood lead test results (not only those greater than or equal to 10 micrograms per deciliter) be reported; and 3. That all reports be submitted via regular mail service on computer diskette or encrypted and emailed
The statute does not require blood lead levels less than 10µg/dL to be reported. 
Lead is an Important Pediatric Health Problem
Despite the elimination of lead from gasoline and interior house paint in this country, lead from these sources remains in the environment and houses. The Centers for Disease
Control and Prevention (CDC) have termed excessive absorption of lead as "one of the most common pediatric health problems in the United States today and it is entirely preventable" (CDC 1991) . Though lead has been eliminated from house paint in this country, lead-based paint hazards in older homes remain the primary source of high-dose lead exposure for preschool-aged children (CDC 1997 :13, Children's Environmental Health Network 1997 .
Children are at particular risk for lead exposure due to their regular hand-to-mouth activity during daily play where lead-based paint is peeling or flaking. The dust from this deteriorating paint is easily ingested and is a significant source of exposure.
Children 9 months of age to 2 1/2 years of age are at greatest risk of lead poisoning.
They have greater hand-to-mouth activity, their brains are more sensitive to the toxic effects of lead, and they absorb a greater percentage of the lead that is ingested. For comparison, where an adult will absorb 10% of ingested lead, a toddler will absorb 50% of ingested lead (Children's Environmental Health Network 1997:1). Childrens' developing nerves are more susceptible because the cell membrane activity and enzymes are affected by lower levels of lead (Cassarett, Dull 1995) . Children less than 72 months of age continue to have increased risk for lead poisoning, which gradually decreases until they are 6 years of age. After 6 years of age, the risk is generally low, but special circumstances may increase risk.
Ingested lead is readily available to a child's body during early growth and development.
Children are very different from adults physiologically. Pound for pound, young children breathe more, eat more and drink more than adults and double their weight in their first four months of life (Children's Environmental Health Network 1997:1). For example, proportionately, an average one-year-old eats two to seven times more grapes, bananas, pears, carrots and broccoli than an adult (Ibid:2). Children have greater need for calcium than do adults for developing bone and will absorb more of this element when it is ingested. If lead is ingested, the body will mistake it for calcium and absorb the lead in place of calcium.
Other effects of lead poisoning may include diminished intelligence, learning disabilities, delayed congenital development, interference with calcium metabolism, reduced heme syntheses (or the body's ability to manufacture red blood cells), reduced kidney function, and damage to the central nervous system. The damage to the central nervous system is not reversible. The extent to which these effects will be present in a child depends on a number of factors, including the duration and intensity of exposure. These factors are still being studied to determine long-term effects of exposure on children.
SELECTED PROGRAM ACTIVITIES CALENDAR YEAR 1999
• The Program compiled and submitted to the CDC, the annual report for 1998 and the four quarterly reports for 1999. The quarterly and annual reports are sent to all 67 county health departments (CHDs) and other interested parties. The report mailing list numbers over 100.
• The program received a total of 32 requests for data since January 1, 1999. Varying degrees of information were requested by concerned parents, researchers from Florida Universities and graduate students whose projects or theses involves lead poisoning, and CHDs. Fulfilling these requests required simple tasks such as providing educational materials or more complex tasks of querying data from the main database and preparing appropriate explanations.
• Comparisons of the screened, elevated blood lead, and confirmed lead poisoned populations, by race sex, and age, for 1999 are shown in graphs 1-6. A summary of the data provided by the Bureau of Laboratories follows:
Graph 1 Screening Tests • 51% were male and 48% were female.
• 43% were African American and 47% were European American. The remaining 10% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
• 91% were between 12 and 72 months of age.
Graph 2 Elevated Screening Tests (All Tests≥10µg/dL)
• 55% were male and 45% female.
• 57% were African American and 37% European American. The remaining 6% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
• 96% were between 12 and 72 months of age.
Graph 3 Confirmed Elevated Screening Test (Venous Tests≥10µg/dL)
• 51% were male and 48% female.
• 74% were African American and 20% were European American. The remaining 6% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
• 98% were between 12 and 72 months of age.
Graph 4
Children (all children <72 months of age tested for blood lead)
• 51% were male and 48% were female.
• 42% were African American and 48% were European American. The remaining 10% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
• 92% were between 12 and 72 months of age.
Graph 5 Children with Elevated Tests (All Tests≥10µg/dL)
• 56% were male and 43% were female.
• 58% were African American and 36% were European American. The remaining 6% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
• 97% were between 12 and 72 months of age.
Graph 6 Children Confirmed as Lead Poisoned (Venous Tests≥10µg/dL)
• 51% were male and 47% were female.
• 73% were African American and 20% were European American. The remaining 7% were composed of Native American, Asian or Pacific Islander, or had unknown race indications.
These data indicate that male children were slightly more likely to be confirmed as lead poisoned. These data also show that over 3 times as many African American children were confirmed as lead poisoned compared to European American children. These data are consistent with national data showing that non-Hispanic blacks are more at risk for lead poisoning than children in other race groups (MMWR, February 21, 1997) One trend in statewide case management appears to be low compliance in follow-up testing for children with initial blood lead levels ≥10µg/dL. Factors that influence follow-up tracking include providers using different laboratories for initial and confirmatory test analysis, incomplete reporting by laboratories and providers, and incomplete demographic information for tested children. Individual counties will need to evaluate local follow-up performance, especially if they use private laboratories for blood lead analyses. • approximately 10.2% of children with initial capillary test results 20-44µg/dL.
• 0% of children with initial capillary test results 45-69µg/dL.
• No initial capillary tests ≥70µg/dL were reported.
The goal is that 100% of children with elevated initial capillary blood lead tests (≥10µg/dL) receive timely follow-up. Ascertaining whether or not capillary testing is an accurate measure of blood lead levels cannot be determined from this data due to the low percentage of initial capillary tests that are followed by a confirmatory venous test in a timely manner.
Private laboratory reporting continues to be challenging for data analysis. For this report, private laboratory data were merged with Bureau of Laboratories' data to facilitate the identification of follow-up tests that were performed by private laboratories (see Tables 2 and  4) . Each laboratory has different reporting deficits. Missing data elements include some or all of the following: children's addresses, test type, date of birth, provider of sample and dates of collection and analysis of sample.
With the exception of LeadTech, which analyzes only capillary samples collected on filter paper, many of all elevated reports for children submitted by private laboratories do not indicate if blood samples drawn were capillary or venous. These private laboratories combined analyze a greater number of samples than the public laboratory alone. Given the magnitude of incomplete records submitted by private laboratories, the program may be underestimating (or overestimating) the extent of lead poisoning in Florida. In order to compile the most accurate representation possible of the screened, elevated blood lead and lead poisoned populations, the program continues efforts to improve completeness and accuracy of data reporting by working with private laboratories. Explanation of Tables and Graphs   TABLE 1. 1999 Data: This table shows the number of specimens collected, the number of children tested (some children may have been tested multiple times), and the number and percentage of children who received Medicaid within each county. "Number of tests done" is a count of the number of blood specimens of sufficient quantity and quality that were received in the specified period. "Number of children tested" is determined by eliminating duplicate records on the same child using the child's last name, first name, and birthday as sort fields. Whether a child is a Medicaid recipient or not is determined by examining if she/he has a corresponding Medicaid number. If there is none, the child is categorized as a non-Medicaid child. The numbers used in this number of specimens collected and the number of children tested (some children may have been tested multiple times). "Number of tests done" is a count of the number of blood specimens of sufficient quantity and quality that were received in the specified period. "Number of children tested" is determined by eliminating duplicate records on the same child using the child's last name, first name, and birthday as sort fields. The numbers used in this table are based on reports received from reporting private laboratories for the time period indicated. Few reporting private laboratories submit Medicaid status, thus it can not be included as in Table 1 . This graph shows the proportion of all reported blood lead analyses by race, gender, and age groups (in months). The total reports received represents all analyses for children less than 72 months of age for whom a blood lead analysis result was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information.
GRAPH 2. 1999 Data: This graph shows the proportion of all reported capillary or venous blood lead analyses ≥10µg/dL by race, gender, and age groups in months. The total reports received represents all analyses for children less than 72 months of age for whom a blood lead analysis result ≥10µg/dL was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information. GRAPH 3. 1999 Data: This graph shows the proportion of all reported venous blood lead analyses ≥10µg/dL by race, gender, and age groups in months. The total reports received represents all analyses for children less than 72 months of age for whom a venous blood lead analysis result ≥10µg/dL was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information. GRAPH 4. 1999 Data: This graph shows the proportion of all children with reported blood lead analyses by race, gender, and age groups (in months). The total population represents all children less than 72 months of age for whom a blood lead analysis result was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information.
GRAPH 5. 1999Data: This graph shows the proportion of all children with capillary or venous blood lead analyses ≥10µg/dL by race, gender, and age groups in months. The total population represents all children less than 72 months of age for whom a blood lead analysis result ≥10µg/dL was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information. GRAPH 6. 1999 Data: This graph shows the proportion of all children with venous blood lead analyses ≥10µg/dL by race, gender, and age groups in months. The total population represents all children less than 72 months of age for whom a venous blood lead analysis result ≥10µg/dL was reported by the Bureau of Laboratories. Private clinical data were not used for this analysis due to lack of demographic information. Alachua  16  3  2  2  0  23   Baker  0  0  0  0  0  0  Bay  0  2  1  0  0  3  Bradford  0  0  0  0  0  0  Brevard  0  10  1  1  0  12  Broward  13  123  24  12  0  172  Calhoun  0  1  1  0  0  2  Charlotte  0  2  0  0  0  2  Citrus  19  1  0  0  0 Estimated number of children aged 1and 2 years, number of Medicaid eligible children aged 1 and 2 years and number of children aged 1and 2 years tested for lead poisoning, by county, based on 1990 census data. on information provided by the Agency for Health Care Administration,and on reports from the Department of Health, Bureau of Laboratories and reporting private laboratories from January 1, 1999 to December 31, 1999. 
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